projects:workgroups:clinicalstudy
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
projects:workgroups:clinicalstudy [2019/02/06 21:58] sdolley |
projects:workgroups:clinicalstudy [2019/05/23 11:52] kees |
||
|---|---|---|---|
| Line 5: | Line 5: | ||
| **Objective:** Understand clinical trial use cases where the OHDSI platform & ecosystem can aid trials in any aspect, and assist in driving updates in OHDSI tools to support. This might be to represent data from interventional trial or observational study in OMOP CDM, might include enabling feasibility analysis, might include trial data collection, supporting biostatistics, or delivering real-world evidence to help trialists, or other. | **Objective:** Understand clinical trial use cases where the OHDSI platform & ecosystem can aid trials in any aspect, and assist in driving updates in OHDSI tools to support. This might be to represent data from interventional trial or observational study in OMOP CDM, might include enabling feasibility analysis, might include trial data collection, supporting biostatistics, or delivering real-world evidence to help trialists, or other. | ||
| - | **Project Lead:** Shawn Dolley (ping on OHDSI forum or shawn@shawndolley.com) | + | **Project Lead:** Shawn Dolley, Gates Foundation (ping on OHDSI forum or shawn@shawndolley.com) |
| **Members:** | **Members:** | ||
| * Andrew Williams, PhD, Tufts | * Andrew Williams, PhD, Tufts | ||
| + | * Greg Klebanov, MS, Odysseus | ||
| * Rupa Makadia, PhD, Janssen | * Rupa Makadia, PhD, Janssen | ||
| * Vojtech Huser, PhD, NIH | * Vojtech Huser, PhD, NIH | ||
| - | * Chris Roeder | + | * Chris Roeder, MS, Colorado |
| * Thomas Falconer, MS, Columbia | * Thomas Falconer, MS, Columbia | ||
| * Josh Ransom, PhD, Medidata | * Josh Ransom, PhD, Medidata | ||
| * Ryan Li, Columbia | * Ryan Li, Columbia | ||
| + | * Ana Heredia, GMV | ||
| + | * Ayesha Kang, Deloitte | ||
| + | * Kees van Bochove, MS, The Hyve | ||
| + | * Maxim Moinat, MS, The Hyve | ||
| + | * Sonia Araujo, PhD, IQVIA | ||
| + | * Jill Hardin, PhD, Janssen | ||
| **Start Date:** 2019 (this started as 'Clinical Study' working group in 2016 and was dormant) | **Start Date:** 2019 (this started as 'Clinical Study' working group in 2016 and was dormant) | ||
| - | **Repository:** To be organized soon. | + | **Repository:** |
| + | |||
| + | * {{:projects:workgroups:using-real-world-evidence-to-optimize-clinical-trials_2018-shyftanalytics.pdf|White Paper: Using RWE in Trials by SHYFT Analytics}} | ||
| + | * {{:projects:workgroups:SHYFT-OHDSI-POSTER.pdf|Poster: Leveraging the OMOP CDMv5 for CDISC SDTM RCT Data}} | ||
| + | * {{https://www.shyftanalytics.com/webinars/7-ways-to-compress-your-clinical-trial/|Webinar: 7 Ways to Compress Your Clinical Trial (registration required)}} | ||
| + | * {{:projects:workgroups:20190423-clinical-trials-and-rwd.pptx|All Identified Use Cases Joining Clinical Trial Data with Real World Data}} | ||
| + | * {{:projects:workgroups:the_hyve_ohdsi_clinical_trials_wg_presentation_20190412.pdf|The Hyve presentation on clinical trials in OMOP 20190412}} | ||
| </WRAP> | </WRAP> | ||
| Line 24: | Line 38: | ||
| ==== Meetings ==== | ==== Meetings ==== | ||
| - | |||
| - | **Forum links:** | ||
| **Current:** Dial-in info below... | **Current:** Dial-in info below... | ||
| + | |||
| + | **Logs of past meetings:** | ||
| + | * {{:projects:workgroups:20190208_ohdsi_ct_wg.docx|Feb 8 2019 Log}} | ||
| + | * {{:projects:workgroups:20190301_2nd_meeting_log_-_march_1_2019_-_ohdsi_ct_wg.docx|March 1 2019 Log}} | ||
| + | * Recording of Mar 15 2019 meeting, unlisted to the public: https://youtu.be/6Wh2BTB6DXU | ||
| + | * {{:projects:workgroups:20190426 Meeting 4-CDISC-to-OHDSI-Odysseus.docx|Apr 26 2019 Log}} | ||
| + | * Recording of Apr 26 2019 meeting, unlisted to the public: Odysseus & Medidata Presentation on Clin Trials to OMOP Common Data Model: https://youtu.be/R8dnOZA6ODE | ||
| + | * Recording of May 10 2019 meeting, unlisted to the public: https://youtu.be/XIuSnsMov8U | ||
| **Old/ Archive** | **Old/ Archive** | ||
| * http://forums.ohdsi.org/t/omop-cdm-and-clinical-trials/2109 | * http://forums.ohdsi.org/t/omop-cdm-and-clinical-trials/2109 | ||
| * http://forums.ohdsi.org/t/requirements-for-clinical-study-trial-data-in-ohdsi/3202 | * http://forums.ohdsi.org/t/requirements-for-clinical-study-trial-data-in-ohdsi/3202 | ||
| - | |||
| - | **Specs:** | ||
| - | |||
| - | **Current: None** | ||
| - | |||
| - | **Old/ Archive** | ||
| * http://www.ohdsi.org/web/wiki/doku.php?id=documentation:next_cdm:clinical_trial | * http://www.ohdsi.org/web/wiki/doku.php?id=documentation:next_cdm:clinical_trial | ||
| Schedule: First & Third Friday of every month (intended). | Schedule: First & Third Friday of every month (intended). | ||
| - | Next Meeting: (Date and Time): Feb 8, 2019 at 12pm Eastern Time US | + | Next Meeting: (Date and Time): Mar 15, 2019 at 10am Eastern Time US |
| Call in Number: | Call in Number: | ||
| Line 51: | Line 65: | ||
| Password: | Password: | ||
| tr*l | tr*l | ||
| - | |||
| - | More ways to join | ||
| - | Join by video system | ||
| - | Dial 628790972@shawndolley.my.webex.com | ||
| - | You can also dial 173.243.2.68 and enter your meeting number. | ||
| - | |||
| Join by phone | Join by phone | ||
| +1-510-338-9438 USA Toll | +1-510-338-9438 USA Toll | ||
| Access code: 628 790 972 | Access code: 628 790 972 | ||
projects/workgroups/clinicalstudy.txt · Last modified: 2024/01/15 15:59 by zhen
Page Tools
